Oncology Specialist - West

United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, Healthcare TechnologyIndustries

Requirements

The Oncology Specialist - West role requires a full-time commitment. While specific educational qualifications are not detailed, the position involves strategic business planning, customer relationship management, sales opportunity identification, and negotiation within company parameters. Proficiency in using CRM databases and developing territory business plans is essential, along with a commitment to completing product and technology training.

Responsibilities

The Oncology Specialist will execute strategic business plans to achieve revenue targets by growing the existing customer base and attracting new customers, particularly early innovator labs. Responsibilities include developing profitable customer accounts through relationship building, identifying and managing sales opportunities, and preparing compelling sales presentations. The role involves negotiating sales, maintaining pricing levels, coordinating sales activities, and managing account details within the CRM database. Additionally, the specialist will build and manage a sales pipeline, provide sales forecast updates, and collaborate with TAM counterparts to support their selling efforts.

Skills

Sales

Business Development

Account Management

Customer Relationship Management

Negotiation

CRM Software

Sales Strategy

Market Analysis

Presentation Skills

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free